edrophonium has been researched along with Syncope in 3 studies
Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.
Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Syncope was induced in 19 of 45 patients with the diagnosis of unexplained syncope." | 5.29 | Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing. ( Dutton, J; Eisenberg, S; Lurie, KG; Mangat, R; Newman, D; Scheinman, M, 1993) |
| "Syncope was induced in 19 of 45 patients with the diagnosis of unexplained syncope." | 1.29 | Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing. ( Dutton, J; Eisenberg, S; Lurie, KG; Mangat, R; Newman, D; Scheinman, M, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, JD | 1 |
| Kim, SG | 1 |
| Ferrick, KJ | 1 |
| Gross, JN | 1 |
| Palma, EC | 1 |
| Scavin, GM | 1 |
| Lurie, KG | 1 |
| Dutton, J | 1 |
| Mangat, R | 1 |
| Newman, D | 1 |
| Eisenberg, S | 2 |
| Scheinman, M | 1 |
| Fitzpatrick, AP | 1 |
| Lee, RJ | 1 |
| Epstein, LM | 1 |
| Lesh, MD | 1 |
| Sheinman, MM | 1 |
1 trial available for edrophonium and Syncope
| Article | Year |
|---|---|
Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation.
Topics: Age Factors; Aged; Aged, 80 and over; Edrophonium; Female; Heart Diseases; Humans; Isoproterenol; Ma | 1996 |
2 other studies available for edrophonium and Syncope
| Article | Year |
|---|---|
Simplified tilt table test protocol with continuous upright position during medication administration and no hydration.
Topics: Edrophonium; Fasting; Humans; Isoproterenol; Middle Aged; Nitroglycerin; Syncope; Tilt-Table Test | 2003 |
Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Edrophonium; Female; Humans; Male; Middle Aged; Posture; | 1993 |